Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AtriCure Inc ATRC

Healthcare Medical Devices
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze... see more

Recent & Breaking News (NDAQ:ATRC)

AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference

Business Wire 9 days ago

AtriCure to Participate in the Stifel 2024 Healthcare Conference

Business Wire November 7, 2024

AtriCure Reports Third Quarter 2024 Financial Results

Business Wire October 29, 2024

AtriCure to Participate in the UBS Global Healthcare Conference

Business Wire October 28, 2024

AtriCure Announces Launch of cryoSPHERE MAX(TM) Probe for Post-Operative Pain Management

Business Wire October 15, 2024

AtriCure to Announce Third Quarter 2024 Financial Results

Business Wire October 8, 2024

AtriCure Receives CE-Mark for the EnCompass® Clamp

Business Wire October 1, 2024

AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini(TM) Device

Business Wire August 27, 2024

AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation

Business Wire August 22, 2024

AtriCure Reports Second Quarter 2024 Financial Results

Business Wire July 30, 2024

AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference

Business Wire July 29, 2024

AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China

Business Wire July 23, 2024

AtriCure to Announce Second Quarter 2024 Financial Results

Business Wire July 9, 2024

AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

Business Wire May 15, 2024

AtriCure Reports First Quarter 2024 Financial Results

Business Wire May 1, 2024

AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference

Business Wire April 30, 2024

AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management

Business Wire April 18, 2024

AtriCure to Announce First Quarter 2024 Financial Results

Business Wire April 10, 2024

AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Business Wire March 26, 2024

AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results

Business Wire February 15, 2024